Replacement of the RPE monolayer

Eye

Volumn 23, Issue 10, 2009, Pages 1910-1915

  Sheridan, C M ^a   Mason, S ^a   Pattwell, D M ^a   Kent, D ^a,b   Grierson, I ^a   Williams, R ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Aut Even Hospital   (Ireland)

Author keywords

AMD; Iris pigment epithelia; RPE; Stem cell; Transplant

Indexed keywords

CYTOKERATIN; MESSENGER RNA;

BRUCH MEMBRANE; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL POPULATION; CELL SURVIVAL; CELL SUSPENSION; CELL TRANSPLANTATION; CONFERENCE PAPER; EMBRYONIC STEM CELL; FOLLOW UP; HUMAN; INTEGRATION; IRIS PIGMENT EPITHELIUM CELL TRANSPLANTATION; NONHUMAN; PIGMENT CELL; PIGMENT EPITHELIUM; RETINA CELL; RETINA MACULA AGE RELATED DEGENERATION; RETINAL PIGMENT EPITHELIUM CELL TRANSPLANTATION; RETINITIS PIGMENTOSA; STEM CELL TRANSPLANTATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT FAILURE;

ANIMALS; CELL TRANSPLANTATION; HUMANS; IRIS; MACULAR DEGENERATION; PIGMENT EPITHELIUM OF EYE; STEM CELL TRANSPLANTATION;

EID: 70350136552     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.420     Document Type: Conference Paper

References (50)

1. Heier JS, Antoszyk AN, Pavan PR, Leff SR, Rosenfeld PJ, Ciulla TA et al. Ranibizumab for treatment of neovascular age-related macular degeneration: A phase I/II multicenter, controlled, multidose study. Ophthalmology 2006; 113: 642-644.
2. Kent D, Sheridan C. Choroidal neovascularization: A wound healing perspective. Mol Vis 2003; 9: 747-755.
3. Tezel TH, Kaplan HJ. Are intravitreal anti-VEGF antibodies safe? Ocul Immunol Inflamm 2007; 15: 1-2.
4. Tezel TH, Del Priore LV, Berger AS, Kaplan HJ. Adult retinal pigment epithelial transplantation in exudative age-related macular degeneration. Am J Ophthalmol 2007; 143: 584-595.
5. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003; 48: 257-293.
6. Forrester JV, Dick AD, McMenamin PG, Lee WR. The eye: basic sciences in practice. W.B. Saunders: London, 2002.
7. Grossniklaus HE, Miskala PH, Green WR, Bressler SB, Hawkins BS, Toth C et al. Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: submacular surgery trials report no. 7. Arch Ophthalmol 2005; 123: 914-921.
8. Bressler NM, Bressler SB, Childs AL, Haller JA, Hawkins BS, Lewis H et al. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology 2004; 111: 1993-2006.
9. Uppal G, Milliken A, Lee J, Acheson J, Hykin P, Tufail A et al. New algorithm for assessing patient suitability for macular translocation surgery. Clin Experiment Ophthalmol 2007; 35: 448-457.
10. van Meurs JC, Van Den Biesen PR. Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: shortterm follow-up. Am J Ophthalmol 2003; 136: 688-695.
11. Stanga PE, Kychenthal A, Fitzke FW, Halfyard AS, Chan R, Bird AC et al. Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration. Ophthalmology 2002; 109: 1492-1498.
12. Sheridan CM, Krishna Y, Williams RL, Mason S, Wong D, Heimann H et al. Transplantation in the treatment of age related macular degeneration: past present and future directions. Expert Rev Ophthalmol 2007; 2: 497-511.
13. Heussen FM, Fawzy NF, Joeres S, Lux A, Maaijwee K, Meurs JC et al. Autologous translocation of the choroid and RPE in age-related macular degeneration: 1-year follow-up in 30 patients and recommendations for patient selection. Eye 2008; 22: 799-807.
14. Joussen AM, Joeres S, Fawzy N, Heussen FM, Llacer H, van Meurs JC et al. Autologous translocation of the choroid and retinal pigment epithelium in patients with geographic atrophy. Ophthalmology 2007; 114: 551-560.
15. MacLaren RE, Uppal GS, Balaggan KS, Tufail A, Munro PM, Milliken AB et al. Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration. Ophthalmology 2007; 114: 561-570.
16. Coffey PJ, Girman S, Wang SM, Hetherington L, Keegan DJ, Adamson P et al. Long-term preservation of cortically dependent visual function in RCS rats by transplantation. Nat Neurosci 2002; 5: 53-56.
17. Lund RD, Adamson P, Sauve Y, Keegan DJ, Girman SV, Wang S et al. Subretinal transplantation of genetically modified human cell lines attenuates loss of visual function in dystrophic rats. Proc Natl Acad Sci USA 2001; 98: 9942-9947.
18. da Cruz L. New developments in age-related macular degeneration. Community Eye Health 2008; 21: 50.
19. Binder S, Krebs I, Hilgers RD, Abri A, Stolba U, Assadoulina A et al. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: A prospective trial. Invest Ophthalmol Vis Sci 2004; 45: 4151-4160.
20. van Meurs JC, ter Averst E, Hofland LJ, van Hagen PM, Mooy CM, Baarsma GS et al. Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br J Ophthalmol 2004; 88: 110-113.
21. Tezel TH, Del Priore LV, Berger AS, Kaplan HJ. Adult retinal pigment epithelial transplantation in exudative age-related macular degeneration. Am J Ophthalmol 2007; 143: 584-595.
22. Kent D, Sheridan CM, Tomkinson HA, White SJ, Hiscott P, Yu L et al. Edible mushroom (Agaricus bisporus) lectin inhibits human retinal pigment epithelial cell proliferation in vitro. Wound Repair Regen 2003; 11: 285-291. (Pubitemid 36897525)
23. Kent D, Sheridan C, Tomkinson HA, White S, Hiscott P, Grierson I. Edible mushroom (Agaricus bisporus) lectin modulates human retinal pigment epithelial cell behaviour in vitro. Exp Eye Res 2003; 76: 213-219. (Pubitemid 36263347)
24. Algvere PV, Gouras P, Dafgard KE. Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD. Eur J Ophthalmol 1999; 9: 217-230.
25. Aramant RB, Seiler MJ. Progress in retinal sheet transplantation. Prog Retin Eye Res 2004; 23: 475-494.
26. Del Priore LV, Ishida O, Johnson EW, Sheng Y, Jacoby DB, Geng L et al. Triple immune suppression increases shortterm survival of porcine fetal retinal pigment epithelium xenografts. Invest Ophthalmol Vis Sci 2003; 44: 4044-4053.
27. Sauve Y, Girman SV, Wang S, Keegan DJ, Lund RD. Preservation of visual responsiveness in the superior colliculus of RCS rats after retinal pigment epithelium cell transplantation. Neuroscience 2002; 114: 389-401.
28. Radtke ND, Aramant RB, Petry HM, Green PT, Pidwell DJ, Seiler MJ. Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium. Am J Ophthalmol 2008; 146: 172-182.
29. Radtke ND, Aramant RB, Seiler MJ, Petry HM, Pidwell D. Vision change after sheet transplant of fetal retina with retinal pigment epithelium to a patient with retinitis pigmentosa. Arch Ophthalmol 2004; 122: 1159-1165.
30. Lappas A, Foerster AM, Weinberger AW, Coburger S, Schrage NF, Kirchhof B. Translocation of iris pigment epithelium in patients with exudative age-related macular degeneration: long-term results. Graefes Arch Clin Exp Ophthalmol 2004; 242: 638-647.
31. Thumann G. Development and cellular functions of the iris pigment epithelium. Surv Ophthalmol 2001; 45: 345-354.
32. Abe T, Yoshida M, Tomita H, Kano T, Sato M, Wada Y et al. Auto iris pigment epithelial cell transplantation in patients with age-related macular degeneration: short-term results. Tohoku J Exp Med 2000; 191: 7-20.
33. Crafoord S, Geng L, Seregard S, Algvere PV. Photoreceptor survival in transplantation of autologous iris pigment epithelial cells to the subretinal space. Acta Ophthalmol Scand 2002; 80: 387-394.
34. Semkova I, Kreppel F, Welsandt G, Luther T, Kozlowski J, Janicki H et al. Autologous transplantation of genetically modified iris pigment epithelial cells: A promising concept for the treatment of age-related macular degeneration and other disorders of the eye. Proc Natl Acad Sci USA 2002; 99: 13090-13095.
35. Lappas A, Weinberger AW, Foerster AM, Kube T, Rezai KA, Kirchhof B. Iris pigment epithelial cell translocation in exudative age-related macular degeneration. A pilot study in patients. Graefes Arch Clin Exp Ophthalmol 2000; 238: 631-641.
36. Thumann G, Aisenbrey S, Schraermeyer U, Lafaut B, Esser P, Walter P et al. Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes. Arch Ophthalmol 2000; 118: 1350-1355.
37. Aisenbrey S, Lafaut BA, Szurman P, Hilgers RD, Esser P, Walter P et al. Iris pigment epithelial translocation in the treatment of exudative macular degeneration: A 3-year follow-up. Arch Ophthalmol 2006; 124: 183-188.
38. Vugler A, Lawrence J, Walsh J, Carr A, Gias C, Semo M et al. Embryonic stem cells and retinal repair. Mech Dev 2007; 124: 807-829.
39. Vugler A, Carr AJ, Lawrence J, Chen LL, Burrell K,Wright A et al. Elucidating the phenomenon of HESC-derived RPE: Anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol 2008; 214(2): 347-361.
40. da CL, Chen FK, Ahmado A, Greenwood J, Coffey P. RPE transplantation and its role in retinal disease. Prog Retin Eye Res 2007; 26: 598-635.
41. Laurent G. Directed issue on stem cells. Int J Biochem Cell Biol 2004; 36: 553.
42. Enzmann V, Howard RM, Yamauchi Y, Whittemore SR, Kaplan HJ. Enhanced induction of RPE lineage markers in pluripotent neural stem cells engrafted into the adult rat subretinal space. Invest Ophthalmol Vis Sci 2003; 44: 5417-5422.
43. Young MJ, Ray J, Whiteley SJ, Klassen H, Gage FH. Neuronal differentiation and morphological integration of hippocampal progenitor cells transplanted to the retina of immature and mature dystrophic rats. Mol Cell Neurosci 2000; 16: 197-205.
44. Harris JR, Brown GA, Jorgensen M, Kaushal S, Ellis EA, Grant MB et al. Bone marrow-derived cells home to and regenerate retinal pigment epithelium after injury. Invest Ophthalmol Vis Sci 2006; 47: 2108-2113.
45. Klassen HJ, Ng TF, Kurimoto Y, Kirov I, Shatos M, Coffey P et al. Multipotent retinal progenitors express developmental markers, differentiate into retinal neurons, and preserve light-mediated behavior. Invest Ophthalmol Vis Sci 2004; 45: 4167-4173.
46. Qiu G, Seiler MJ, Mui C, Arai S, Aramant RB, de Juan Jr E et al. Photoreceptor differentiation and integration of retinal progenitor cells transplanted into transgenic rats. Exp Eye Res 2005; 80: 515-525.
47. Limb GA, Daniels JT, Cambrey AD, Secker GA, Shortt AJ, Lawrence JM et al. Current prospects for adult stem cell-based therapies in ocular repair and regeneration. Curr Eye Res 2006; 31: 381-390.
48. Coles BL, Angenieux B, Inoue T, Del Rio-Tsonis K, Spence JR, McInnes RR et al. Facile isolation and the characterization of human retinal stem cells. Proc Natl Acad Sci USA 2004; 101: 15772-15777.
49. Sheridan CM, Mason S, Williams RL, Grierson I. Isolation and culture of retinal stem cells for the potential treatment of Age-related Macular Degeneration. Clin Experiment Ophthalmol 2008; 36(1): 523.
50. Sheridan CM, Krishna Y, Williams RL, Mason S, Wong D, Heimann H et al. Transplantation in the treatment of age related macular degeneration: past present and future directions. Expert Rev Ophthalmol 2007; 2: 497-511.